Poor research practice suggests that the true impact of homeopathy may be substantially overestimated, finds an analysis of the current body of evidence on the effectiveness of this type of complementary medicine, published ...
Mar 16, 2022
0
68
A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN). Details on the trial, which supported ...
Apr 24, 2019
0
23
(Medical Xpress)—A small team of researchers with the University of Basel in Switzerland has conducted a study of risk preference in people and has found evidence that suggests risk preference should be considered a psychological ...
A newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy and systemic therapy after surgery to treat patients with endometrial cancer. ...
Dec 7, 2022
0
2
As men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body's ability to fight cancer, according to new research from Cedars-Sinai Cancer.
Jun 21, 2023
0
102
Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating ...
Jul 9, 2020
0
7
The kidneys of patients living with systemic lupus erythematosus (SLE) are often under assault, and not all those living with the disease will respond to standard treatment. A new report published in the journal Nature Immunology ...
May 20, 2019
0
219
Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death from the disease.
Dec 28, 2021
0
35
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in a clinical trial.
Aug 19, 2019
0
8
A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better understanding ...
May 16, 2019
0
234
